NVO – novo nordisk a/s (US:NASDAQ)

News

Assessing Novo Nordisk After Recent Volatility and Debate Over Obesity Drug Pricing [Yahoo! Finance]
Novo Nordisk (NVO) Rises Higher Than Market: Key Facts [Yahoo! Finance]
Omeros: Stock Pops On Yartemlea Approval, Longer-Term Upside Likely [Seeking Alpha]
FDA approves Novo Nordisk's weight-loss pill [FOX Business Network]
Novo Nordisk: The Real Comeback Starts Now With The Wegovy Pill [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com